Characterization of MHC Class I and Class II Immunopeptides in Lung Cancer From Needle-sized Biopsies Using an Optimized High-throughput Workflow
Posters
Poster presented at ASBMB 2022
Presenter: Nigel Beaton
Sunday, August 14
You are leaving Biognosys.com for Bruker.com.
Do you want to proceed?
Take me to Bruker.com
No, thank you. I will stay.